Research Institute for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran
Abstract
In this report, the clinical course and treatment response of 210 patients with Grawes’ disease referred to the research institute for nuclear medicine were studied. The disease was more common in 3rd and 4th decades and more frequent in women (F/M=4). Treatment response with antithyroid drugs was about 50%, whereas 80% of the patients treated by I-131 showed positive response. There was no meaningful relation between treatment response and thyroid size or the dose of I-131.
Fard-Esfahani, A., Ramezani Aval, M., Rezaie, A., Eftekhari, M., & Saghari, M. (2000). Retrospective study of clinical course and treatment response in Graves’ disease [Persian]. Iranian Journal of Nuclear Medicine, 8(1), 10-14.
MLA
Armaghan Fard-Esfahani; Mehdi Ramezani Aval; Alireza Rezaie; Mohammad Eftekhari; Mohsen Saghari. "Retrospective study of clinical course and treatment response in Graves’ disease [Persian]". Iranian Journal of Nuclear Medicine, 8, 1, 2000, 10-14.
HARVARD
Fard-Esfahani, A., Ramezani Aval, M., Rezaie, A., Eftekhari, M., Saghari, M. (2000). 'Retrospective study of clinical course and treatment response in Graves’ disease [Persian]', Iranian Journal of Nuclear Medicine, 8(1), pp. 10-14.
VANCOUVER
Fard-Esfahani, A., Ramezani Aval, M., Rezaie, A., Eftekhari, M., Saghari, M. Retrospective study of clinical course and treatment response in Graves’ disease [Persian]. Iranian Journal of Nuclear Medicine, 2000; 8(1): 10-14.
)